Why the same condition produces such different numbers
The headline figure of about 50% comes from a review of the comorbidity between chronic pain and insomnia, which describes the two conditions as highly co-occurring and mutually reinforcing [4]. That number is a useful anchor, but it is a broad estimate across chronic pain populations rather than a single measured rate.
Where researchers look changes what they find. A registry-based study of 6,497 adults with chronic non-cancer pain in Sweden found insomnia in 62.3% of patients [5]. That is a clinical population—people whose pain was serious enough to be recorded in a quality registry for pain rehabilitation—so it captures a more affected group than a random sample of the community would.
The gap between settings is even starker in the thesis work on patients seeking specialized pain care, which reported that insomnia was roughly six times more common in that sample than in the general population [2]. The comparison is between people actively seeking help for pain and everyone else, so it partly reflects who shows up for treatment rather than a pure difference in biology.
How you define insomnia changes the count
Part of the variation is definitional. A study of chronic musculoskeletal pain specifically examined how different insomnia classification methods affect prevalence estimates, and found that the choice of classification method shifts the numbers [1]. In other words, two studies can examine similar patients and report different rates simply because they drew the line between "insomnia" and "not insomnia" in different places.
This matters for reading any single percentage. A rate of 50%, 62%, or higher is not a fixed property of chronic pain; it is the product of a particular sample and a particular threshold. The thesis work also found that the link between insomnia symptoms and other variables—mainly psychological symptoms and pain intensity—was weak, suggesting that insomnia in chronic pain is not simply a byproduct of worse pain or distress [2].
What community and occupational samples can and cannot tell us
Direct comparisons between clinical and community samples are scarce in this evidence. The studies that report clinical rates explicitly note that they did not compare clinical and community groups [1][2][5]. A study of metro train drivers in Madrid examined chronic pain and insomnia in a specific occupational community, but it does not compare clinical and community samples either [3].
That leaves the clinical-versus-community contrast inferred rather than measured head-to-head. The most defensible reading is that clinical samples—people in pain registries or specialized care—show high rates, in the 50–62% range or above [4][5], while the general-population comparison in the thesis suggests clinical rates are several times higher than background rates [2]. The size of that gap should be treated as approximate, since no study here directly pitted the two sampling frames against each other.
Why the pairing matters beyond the percentage
The comorbidity is not just a counting exercise. In the clinical thesis, moderate and severe insomnia symptoms were associated with a dose-dependent increase in the risk of pain spreading, while sub-threshold symptoms showed no such increase [2]. That suggests severity, not just presence, may matter for how pain evolves.
The review paper proposes that shared cognitive biases—such as attentional and interpretation biases—could help explain why the two conditions maintain each other, though the authors describe this evidence as preliminary and sparse [4]. Separately, the registry study found that catastrophizing and acceptance mediated part of the relationship between insomnia and pain intensity, though the combined mediating effects were weaker than the direct link [5]. These are proposed mechanisms, not settled causes, but they point to why clinicians increasingly treat sleep and pain together rather than in isolation.
Sources used in this answer
How insomnia classification influences prevalence estimates and clinical comparisons in chronic musculoskeletal pain: a cross-sectional study
Different insomnia classification methods produce different prevalence estimates in chronic musculoskeletal pain, and the study compares clinical parameters between insomnia and non-insomnia groups without comparing clinical and community samples.
Insomnia Symptoms in Chronic Pain : Clinical presentation, risk and treatment
In patients seeking specialized pain care, insomnia was roughly six times more common than in the general population, and moderate-to-severe insomnia symptoms were associated with a dose-dependent increase in risk of pain spreading.
CHRONIC PAIN AND INSOMNIA DISORDER IN METRO TRAIN DRIVERS IN THE COMMUNITY OF MADRID. PREVALENCE AND ASSOCIATED FACTORS
The study estimates the prevalence of chronic pain and insomnia and their associated factors among metro train drivers in Madrid, a specific occupational community, without comparing clinical and community samples.
Chronic Pain, Insomnia and their Mutual Maintenance: A Call for Cognitive Bias Research
Approximately 50% of people with chronic pain experience insomnia or clinically significant sleep disturbance, and about 50% of people with insomnia experience chronic pain.
Catastrophizing and acceptance are mediators between insomnia and pain intensity—an SQRP study of more than 6,400 patients with non-malignant chronic pain conditions
In a registry cohort of 6,497 adults with chronic non-cancer pain, insomnia prevalence was 62.3%, with catastrophizing and acceptance among the strongest mediators between insomnia and pain intensity.